Matthew E. Korenberg - Aug 22, 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Matthew E. Korenberg
Stock symbol
LGND
Transactions as of
Aug 22, 2024
Transactions value $
-$1,986,420
Form type
4
Date filed
8/26/2024, 08:15 PM
Previous filing
Aug 21, 2024
Next filing
Sep 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale -$122K -1.16K -1.69% $105.54 67.2K Aug 22, 2024 Direct F1
transaction LGND Common Stock Sale -$212K -2.04K -3.03% $104.09 65.2K Aug 23, 2024 Direct F2
transaction LGND Common Stock Sale -$449K -4.28K -6.56% $105.13 60.9K Aug 23, 2024 Direct F3
transaction LGND Common Stock Sale -$649K -6.18K -10.14% $105.02 54.7K Aug 26, 2024 Direct F4
transaction LGND Common Stock Sale -$554K -5.21K -9.52% $106.32 49.5K Aug 26, 2024 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.2500 to $105.6500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.4450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.7200 to $105.6700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.8100 to $106.6900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.